Millennium Management’s Tenaya Therapeutics TNYA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.78M Buy
5,456,666
+840,920
+18% +$621K ﹤0.01% 3247
2025
Q4
$3.28M Buy
4,615,746
+111,154
+2% +$151K ﹤0.01% 3459
2025
Q3
$7.3M Buy
4,504,592
+3,823,848
+562% +$3.85M ﹤0.01% 2718
2025
Q2
$416K Buy
680,744
+638,694
+1,519% +$325K ﹤0.01% 5020
2025
Q1
$24K Sell
42,050
-112,178
-73% -$111K ﹤0.01% 5612
2024
Q4
$221K Sell
154,228
-174,447
-53% -$391K ﹤0.01% 5251
2024
Q3
$634K Buy
328,675
+48,014
+17% +$136K ﹤0.01% 4635
2024
Q2
$870K Sell
280,661
-94,441
-25% -$390K ﹤0.01% 4194
2024
Q1
$1.96M Sell
375,102
-127,568
-25% -$610K ﹤0.01% 3759
2023
Q4
$1.63M Sell
502,670
-234,903
-32% -$507K ﹤0.01% 3777
2023
Q3
$1.88M Buy
737,573
+399,764
+118% +$1.67M ﹤0.01% 3606
2023
Q2
$1.98M Buy
337,809
+177,201
+110% +$1.03M ﹤0.01% 3494
2023
Q1
$458K Buy
160,608
+48,415
+43% +$136K ﹤0.01% 4660
2022
Q4
$226K Buy
112,193
+15,168
+16% +$37K ﹤0.01% 5260
2022
Q3
$281K Buy
97,025
+85,398
+734% +$399K ﹤0.01% 5435
2022
Q2
$65K Buy
+11,627
New +$94.1K ﹤0.01% 6091
2021
Q4
Sell
-106,851
Closed -$2.21M 7381
2021
Q3
$2.21M Buy
+106,851
New +$2.3M ﹤0.01% 3791

Other funds holding TNYA

Millennium Management's TNYA Position: Q1 2026 in Review

Millennium Management increased its Tenaya Therapeutics (TNYA) stake by 18% in Q1 2026, buying an estimated $621K and bringing the position to 5,456,666 shares worth $3.78M. The position accounts for ﹤0.01% of the portfolio, ranked #3247.

Millennium Management first reported a position in TNYA in Q3 2021 and has held it in 17 quarters since. The position peaked at $7.3M in Q3 2025. 103 funds tracked by Wall St. Rank hold TNYA as of Q1 2026.

  • Millennium Management held 5,456,666 shares of Tenaya Therapeutics worth $3.78M as of Q1 2026.
  • Millennium Management bought 840,920 Tenaya Therapeutics shares in Q1 2026, an estimated $621K.
  • Tenaya Therapeutics made up ﹤0.01% of Millennium Management's portfolio in Q1 2026, its #3247 holding.
  • Millennium Management first reported a position in Tenaya Therapeutics in Q3 2021 and has held it in 17 quarters since.
  • Millennium Management's Tenaya Therapeutics position peaked at $7.3M in Q3 2025.
  • 103 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.